CompletedNot Applicable

Comparative Effects of Paraffin Bath Therapy and ESWT in Patients With De Quervain Tenosynovitis

Turkey (Türkiye)70 participantsStarted 2022-07-25

Plain-language summary

There is no study in the literature comparing both paraffin bath therapy and Extracorporeal Shock Wave Therapy (ESWT) in the treatment of patients with De Quervain Tenosynovitis. The aim of this study is performing this comparison.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being 18 years or older * Meeting De Quervain diagnostic criteria * Not having applied any physical therapy modality to the hand-wrist in the last 1 month * Not using pain medication in the last 1 month, * Not using local anesthetics or steroid injections on the hand-wrist in the last 3 months * Have received written consent to participate in the study, and have come to the last control at the 6th week. Exclusion Criteria: * Neurological diseases (especially neuropathies), * Malignancy, * Rheumatological diseases * Pregnancy * History of hand/wrist fracture or surgery * Hand/wrist trauma in the last 1 month * Coagulation disorder diseases

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Visual Analogue Scale (VAS)

Timeframe: at baseline (before the treatment)

Visual Analogue Scale (VAS)

Timeframe: 2 weeks after baseline (at the end of treatment)

Visual Analogue Scale (VAS)

Timeframe: 6 weeks after baseline (one month after the end of treatment)

Duruöz Hand Index (DHI)

Timeframe: at baseline (before the treatment)

Duruöz Hand Index (DHI)

Timeframe: 2 weeks after baseline (at the end of treatment)

Duruöz Hand Index (DHI)

Timeframe: 6 weeks after baseline (one month after the end of treatment)

Trial details

NCT IDNCT05423353

SponsorYuzuncu Yil University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-05

View on ClinicalTrials.gov More De Quervain Disease trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Visual Analogue Scale (VAS)

Timeframe: at baseline (before the treatment)

Visual Analogue Scale (VAS)

Timeframe: 2 weeks after baseline (at the end of treatment)

Visual Analogue Scale (VAS)

Timeframe: 6 weeks after baseline (one month after the end of treatment)

Duruöz Hand Index (DHI)

Timeframe: at baseline (before the treatment)

Duruöz Hand Index (DHI)

Timeframe: 2 weeks after baseline (at the end of treatment)

Duruöz Hand Index (DHI)

Timeframe: 6 weeks after baseline (one month after the end of treatment)